EVERADS THERAPY
Everads Therapy is a revolutionary drug and cell delivery system developing a simple treatment approach that allows for delivery of therapies into the back of the eye addressing challenges in treatment of retinal diseases. Its platform is consists of a blunt injector for applying its access method to targeting the back of the eye. Everads Therapy was founded in 2016 and is based in Tel Aviv, Israel.
EVERADS THERAPY
Social Links:
Industry:
Health Care Medical Device Pharmaceutical
Founded:
2016-10-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.everads-therapy.com
Total Employee:
1+
Status:
Active
Contact:
+97237684943
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google
Current Employees Featured
Founder
Official Site Inspections
http://www.everads-therapy.com Semrush global rank: 9.54 M Semrush visits lastest month: 141
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Everads Therapy"
EVERADS THERAPY
Everads Enters into Collaboration to Evaluate its Suprachoroidal Delivery Technology with a Clinical-Stage Gene Therapy Company - Under new collaboration, partner given opt-in right to โฆSee details»
Everads Therapy - Crunchbase Company Profile & Funding
Everads Therapy is a revolutionary drug and cell delivery system developing a simple treatment approach that allows for delivery of therapies into the back of the eye addressing challenges in โฆSee details»
Everads Therapy Ltd - LinkedIn
Everads Therapy Ltd | 293 followers on LinkedIn. Optimizing Treatment of Retinal Disease by Leveraging Novel Delivery Technology | Everads Therapy is an early-stage life sciences company ...See details»
Everads Therapy Enters Into Option Agreement With Global
Mar 12, 2020 Everads Therapy Ltd. is a lifesciences company developing a revolutionary drug and cell-therapy delivery system for delivering injectable therapies to the back of the eye. With โฆSee details»
Everads Therapy Enters Into Option Agreement With Global โฆ
Mar 12, 2020 Everads Therapy Ltd. is a lifesciences company developing a revolutionary drug and cell-therapy delivery system for delivering injectable therapies to the back of the eye.See details»
Everads Presents Clinical Data from First-in-Human Trial of ...
Sep 19, 2024 Everads Therapy, a clinical stage biotechnology company developing a platform for non-surgical delivery of therapeutics to the back of the eye via the suprachoroidal space, โฆSee details»
Everads Enters License Agreement with Kriya for Development of โฆ
Sep 27, 2023 Everads Therapy is a biotech company focused on optimizing treatment of retinal diseases using its proprietary suprachoroidal delivery technology. With the aim of overcoming โฆSee details»
About - Everads Therapy
Everads is an emerging startup with novel delivery technology to treat retinal diseases via suprachoroidal administration and is developing an early-stage pipeline that leverages our โฆSee details»
Israel's Everads Showcases Breakthrough Suprachoroidal Delivery ...
Sep 24, 2024 Israelโs Everads Therapy is a biotech startup developing optimized retinal therapies by leveraging its novel suprachoroidal delivery technology. The firm released the โฆSee details»
Team - Everads Therapy
Co-founder of Everads and CTO at Dali Medical Devices. Prof. Ygal Rotenstreich, MD. Co-founder at Everads. Head, Electrophysiology Clinic. Director ,Retinal Research Laboratory . Sheba Medical Center. Avner Ingerman, MD. โฆSee details»
Everads Enters into Collaboration to Evaluate its ... - BioSpace
Jun 30, 2021 Everads Therapy is an ophthalmology-focused life sciences company whose goal is to restore vision of patients by enabling optimal treatment of debilitating retinal diseases via โฆSee details»
VivaVision and Everads Collaborate to Develop Durable and โฆ
Jan 6, 2023 Everads Therapy is a biotech company focused on optimizing treatment of retinal diseases using its proprietary suprachoroidal delivery technology. With the aim of overcoming โฆSee details»
Partnerships | Everads Therapy
Everads has a number of collaborations with pharma and biotech companies to leverage our technology for delivering various drug- and gene therapy via the suprachoroidal space (see โฆSee details»
Everads Therapy presented on first-in-human study of the Everads ...
Oct 9, 2024 According to the company, Everads suprachoroidal delivery technology is designed to enable safe and effective in-office delivery of therapies to the choroidal and retinal tissues โฆSee details»
VivaVision, Everads collaborate to develop therapies for retinal โฆ
Jan 6, 2023 VivaVision and Everads Therapy announced today that they are partnering to develop safer, more effective, and more durable treatments for retinal diseases. According to a โฆSee details»
Everads Presents Clinical Data from First-in-Human Trial of ...
Sep 19, 2024 Everads Therapy is a biotech company focused on optimizing treatment of retinal diseases using its proprietary suprachoroidal delivery technology. With the aim of overcoming โฆSee details»
Research programme: small molecule therapeutics - Everads Therapy
Small molecule therapeutics are being developed Everads Therapy, for the treatment of corneal neovascularisation and inflammation. Everads Therapy's innovative Research programme: โฆSee details»
Our Technology - Everads Therapy
Our technology facilitates targeted, rapid delivery of therapy via the emerging suprachoroidal delivery route. Leveraging our technology, we are developing treatments to improve efficacy โฆSee details»
Everads Enters into Collaboration to Evaluate its Suprachoroidal ...
Jun 30, 2021 Everads Therapy is an ophthalmology-focused life sciences company whose goal is to restore vision of patients by enabling optimal treatment of debilitating retinal diseases via โฆSee details»